Aptose Biosciences Inc. - Common Shares

Historical Holders from Q4 2014 to Q1 2025

CUSIP
03835T200
Type / Class
Equity / Common Shares
Shares outstanding
2.56M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
19.6K
Holdings value
$4.41K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
2
Number of buys
1
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aptose Biosciences Inc. - Common Shares

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Hanmi Pharmaceutical Co., Ltd. 19.9% $115K 509K Hanmi Pharmaceutical Co., Ltd. Mar 18, 2025

Institutional Holders of Aptose Biosciences Inc. - Common Shares

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$21 0
2024 Q4 19.6K $4.41K +$4.39K $0.23 2
2024 Q3 92 $38.00 $0 $0.41 1
2024 Q2 92 $70.00 -$44K $0.76 1
2024 Q1 26.8K $44.2K -$79.2K $1.66 2
2023 Q4 74.8K $188K $0 $2.53 2
2023 Q3 74.8K $209K +$59.7K $2.80 2
2023 Q2 53.4K $247K -$16.4M $4.64 2
2023 Q1 21M $13.4M -$1.03M $0.64 42
2022 Q4 23M $13.3M -$981K $0.58 47
2022 Q3 24.5M $14.6M -$330K $0.60 45
2022 Q2 25M $18.6M -$2.73M $0.74 41
2022 Q1 28.5M $38.8M -$3.58M $1.36 50
2021 Q4 31.2M $42.4M -$20.8M $1.35 56
2021 Q3 39.6M $86.4M -$14.1M $2.18 61
2021 Q2 47.2M $157M -$38.4M $3.32 62
2021 Q1 52.4M $313M +$27.3M $5.98 70
2020 Q4 48.7M $214M -$10.7M $4.38 64
2020 Q3 46.4M $278M +$62.5M $6.00 62
2020 Q2 35.9M $227M +$4.42M $6.31 56
2020 Q1 34.6M $205M +$26.2M $5.94 49
2019 Q4 30.7M $174M +$81.2M $5.67 55
2019 Q3 14.2M $29.6M +$4.63M $2.08 30
2019 Q2 11.9M $31.1M +$22.6M $2.61 28
2019 Q1 3.29M $6.62M +$430K $2.00 20
2018 Q4 3.09M $5.9M +$3.41M $1.91 17
2018 Q3 1.07M $2.78M +$884K $2.60 14
2018 Q2 845K $3.28M +$1.47M $3.94 20
2018 Q1 478K $1.51M +$478K $3.17 14
2017 Q4 355K $795K +$420K $2.24 13
2017 Q3 169K $250K -$1.1M $1.48 9
2017 Q2 1.08M $1.33M -$1.37M $1.24 6
2017 Q1 2.43M $2.47M -$371K $1.03 9
2016 Q4 2.64M $3.62M -$280K $1.40 9
2016 Q3 2.9M $6.53M +$885K $2.25 10
2016 Q2 2.5M $6.16M -$322K $2.44 10
2016 Q1 2.63M $7.73M -$16.1K $2.95 12
2015 Q4 2.63M $6.76M -$502K $2.53 9
2015 Q3 2.75M $12M -$703K $4.31 12
2015 Q2 2.91M $14.9M -$54.1K $5.10 14
2015 Q1 2.92M $15.8M -$1.29M $5.42 13
2014 Q4 3.16M $18.7M +$18.7M $5.92 7